Autopsy report · NCT01260103

Phase 3 Study of ANP Therapy vs. TMZ for Optic Pathway Glioma

“Withdrawn: study halted prematurely, prior to enrollment of first participant”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 3

Sponsor

Burzynski Research Institute

Sponsor type

University, hospital or other

Conditions

Optic Nerve Glioma

Interventions

Temozolomide; ANP Therapy

Participants

0

Trials that died the same way

• Cancer and Mild Cognitive Impairment a Patient-Caregiver Behavioral Intervention
  “Study halted prematurely, prior to enrollment of first participant” (85% match in meaning)
• Ozurdex Monotherapy Trial
  “The study was withdrawn due to insufficient participant enrollment.” (84% match in meaning)
• Crossover Evaluation of Effect of Atorvastatin on PK of Irinotecan in CRC Patients Receiving FOLFIRI
  “Study was withdrawn due to lack of patient enrollment.” (84% match in meaning)
• Effects of AffronEye®/ Crocuvis+® on Dry Eye Syndrome
  “Study withdrawn prior to enrollment due to sponsor decision” (82% match in meaning)
• EPIC- Extracorporeal Photopheresis (ECP) for Immune-related Colitis
  “Study Withdrawn by Sponsor prior to Enrollment.” (81% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.